World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT03506984
Date of registration: 15/03/2018
Prospective Registration: No
Primary sponsor: Cairo University
Public title: HIIT Versus IMT on Modulating Blood Rheology in CAD Risk Factors
Scientific title: High Intensity Interval Training Versus Inspiratory Muscle Training on Modulating Blood Rheology in Coronary Artery Disease Risk Factors
Date of first enrolment: September 1, 2017
Target sample size: 40
Recruitment status: Unknown status
URL:  https://clinicaltrials.gov/show/NCT03506984
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Single (Participant).  
Phase:  N/A
Countries of recruitment
Oman
Contacts
Name:     Rana H Elbanna, master
Address: 
Telephone:
Email:
Affiliation:  lecturer assistance at faculty of physical therapy at Cairo University
Name:     Rana H Elbanna, master
Address: 
Telephone: 00201120636626
Email: rana.elbanna@yahoo.com
Affiliation: 
Name:     Mohamed M Habib, master
Address: 
Telephone: 0096899575015
Email: dpthabib@gmail.com
Affiliation: 
Key inclusion & exclusion criteria

Inclusion Criteria:

1. They will be 45-55 years old participants of males.

2. All of them had body mass index more than 30 kg/m2.

3. All of them were diagnosed as diabetic persons for at least 5 years.

4. All of them were diagnosed as a mild to moderate hypertensive persons for at least 5
years.

5. All of them had a reduction in walking capacity in relation to their height, age and
body mass index (BMI).

Exclusion Criteria:

1. Unstable cardiac condition.

2. Patient who were on beta blocker.

3. Uncontrolled diabetes mellitus.

4. Mentally unstable person.

5. Patient with intermittent claudication.



Age minimum: 45 Years
Age maximum: 55 Years
Gender: Male
Health Condition(s) or Problem(s) studied
Coronary Artery Disease, Early-Onset
Intervention(s)
Device: Threshold Inspiration Muscle Training Device
Device: Electronic Bicycle Ergometer
Primary Outcome(s)
Compare between the effect of High Intensity Interval Training versus Inspiratory Muscle Training on modulating lipid profile ( cholesterol level mg/dl, triglyceride mg/dl, LDL mg/dl and HDL mg/dl) by using the blood analyzer in CAD risk factors [Time Frame: after 4 weeks of the trial application]
Secondary Outcome(s)
Compare between the effect of High Intensity Interval Training versus Inspiratory Muscle Training on modulating hematocrit value by using the blood analyzer in CAD risk factors [Time Frame: after 4 weeks of the trial application]
Effect of high intensity interval training and Inspiratory Muscle Training on pulse rate (beat/min) [Time Frame: after 4 weeks of the trial application]
Effect of high intensity interval training and Inspiratory Muscle Training on modified BORG scale by meter [Time Frame: after 4 weeks of the trial application]
Effect of high intensity interval training and Inspiratory Muscle Training on 6 minutes walking test by meter [Time Frame: after 4 weeks of the trial application]
Secondary ID(s)
Rana Elbanna
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history